EI
EAM Investors Portfolio holdings
AUM
$660M
1-Year Return
271.72%
This Quarter Return
+47.61%
1 Year Return
+271.72%
3 Year Return
+5,059.16%
5 Year Return
+72,876.1%
10 Year Return
+9,525,914.37%
AUM
$664M
AUM Growth
+$53.7M
(+8.8%)
Cap. Flow
-$18.4M
Cap. Flow
% of AUM
-2.77%
Top 10 Holdings %
Top 10 Hldgs %
8.56%
Holding
488
New
196
Increased
26
Reduced
99
Closed
166
Top Buys
| 1 |
Atkore
ATKR
|
+$5.77M |
| 2 |
Aclaris Therapeutics
ACRS
|
+$5.17M |
| 3 |
Herc Holdings
HRI
|
+$4.75M |
| 4 |
Champion Homes, Inc.
SKY
|
+$4.73M |
| 5 |
Civitas Resources
CIVI
|
+$4.69M |
Top Sells
| 1 |
Artisan Partners
APAM
|
+$7.7M |
| 2 |
Gentex
GNTX
|
+$7.08M |
| 3 |
Ocular Therapeutix
OCUL
|
+$6.06M |
| 4 |
Celsius Holdings
CELH
|
+$5.29M |
| 5 |
GrowGeneration
GRWG
|
+$5.23M |
Sector Composition
| 1 | Technology | 21.01% |
| 2 | Consumer Discretionary | 19.32% |
| 3 | Industrials | 18.48% |
| 4 | Healthcare | 16.09% |
| 5 | Financials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Atara Biotherapeutics
ATRA
$85.1M
| – | – |
-1,987
| Closed | -$975K |
|
377
Astronics
ATRO
$1.41B
| – | – |
-80,564
| Closed | -$1.07M |
|
378
Bloom Energy
BE
$15.7B
| – | – |
-74,149
| Closed | -$2.13M |
|
379
Beam Therapeutics
BEAM
$2.08B
| – | – |
-23,642
| Closed | -$1.93M |
|
380
Beam Global
BEEM
$42.2M
| – | – |
-14,248
| Closed | -$1.05M |
|
381
Big 5 Sporting Goods
BGFV
$32.8M
| – | – |
-100,461
| Closed | -$1.03M |
|
382
BlackLine
BL
$3.36B
| – | – |
-21,288
| Closed | -$2.84M |
|
383
BioLife Solutions
BLFS
$1.22B
| – | – |
-47,636
| Closed | -$1.9M |
|
|
BPMC
384
DELISTED
Blueprint Medicines
BPMC
| – | – |
-19,813
| Closed | -$2.22M |
|
385
Broadwind
BWEN
$51.6M
| – | – |
-160,186
| Closed | -$1.27M |
|
386
BlueLinx
BXC
$617M
| – | – |
-33,460
| Closed | -$979K |
|
387
Cardlytics
CDLX
$59.6M
| – | – |
-15,481
| Closed | -$2.21M |
|
388
CareDx
CDNA
$720M
| – | – |
-30,186
| Closed | -$2.19M |
|
|
389
Celsius Holdings
CELH
$14.9B
| – | – |
-315,204
| Closed | -$5.29M |
|
390
Chefs' Warehouse
CHEF
$2.7B
| – | – |
-118,358
| Closed | -$3.04M |
|
391
Celldex Therapeutics
CLDX
$1.62B
| – | – |
-100,259
| Closed | -$1.76M |
|
392
Cleveland-Cliffs
CLF
$5.78B
| – | – |
-142,647
| Closed | -$2.08M |
|
393
ClearPoint Neuro
CLPT
$298M
| – | – |
-105,928
| Closed | -$1.68M |
|
394
Core Molding Technologies
CMT
$182M
| – | – |
-88,048
| Closed | -$1.24M |
|
395
Coherent
COHR
$16B
| – | – |
-37,590
| Closed | -$2.86M |
|
396
Cardiff Oncology
CRDF
$136M
| – | – |
-45,517
| Closed | -$819K |
|
397
CorMedix
CRMD
$966M
| – | – |
-120,002
| Closed | -$892K |
|
398
Cerence
CRNC
$450M
| – | – |
-51,791
| Closed | -$5.2M |
|
399
Champions Oncology
CSBR
$94.2M
| – | – |
-99,763
| Closed | -$1.08M |
|
400
Castle Biosciences
CSTL
$621M
| – | – |
-26,357
| Closed | -$1.77M |
|